89 related articles for article (PubMed ID: 26617952)
1. Signaling pathway and molecular subgroups of medulloblastoma. Int J Clin Exp Pathol. 2013; 6(7): 1211-22.
Li KK; Lau KM; Ng HK
Int J Clin Exp Pathol; 2015; 8(9):11945. PubMed ID: 26617952
[TBL] [Abstract][Full Text] [Related]
2. Signaling pathway and molecular subgroups of medulloblastoma.
Li KK; Lau KM; Ng HK
Int J Clin Exp Pathol; 2013; 6(7):1211-22. PubMed ID: 23826403
[TBL] [Abstract][Full Text] [Related]
3. Medulloblastoma: optimizing care with a multidisciplinary approach.
Thomas A; Noël G
J Multidiscip Healthc; 2019; 12():335-347. PubMed ID: 31118657
[TBL] [Abstract][Full Text] [Related]
4. Medulloblastoma stem cells: where development and cancer cross pathways.
Manoranjan B; Venugopal C; McFarlane N; Doble BW; Dunn SE; Scheinemann K; Singh SK
Pediatr Res; 2012 Apr; 71(4 Pt 2):516-22. PubMed ID: 22430388
[TBL] [Abstract][Full Text] [Related]
5. Medulloblastoma molecular dissection: the way toward targeted therapy.
Remke M; Ramaswamy V; Taylor MD
Curr Opin Oncol; 2013 Nov; 25(6):674-81. PubMed ID: 24076581
[TBL] [Abstract][Full Text] [Related]
6. Methylation Profiling of Medulloblastoma in a Clinical Setting Permits Sub-classification and Reveals New Outcome Predictions.
Alharbi M; Mobark N; Bashawri Y; Abu Safieh L; Alowayn A; Aljelaify R; AlSaeed M; Almutairi A; Alqubaishi F; AlSolme E; Ahmad M; Al-Banyan A; Alotabi FE; Serrano J; Snuderl M; Al-Rashed M; Abedalthagafi M
Front Neurol; 2020; 11():167. PubMed ID: 32265819
[TBL] [Abstract][Full Text] [Related]
7. Medulloblastoma targeted therapy: From signaling pathways heterogeneity and current treatment dilemma to the recent advances in development of therapeutic strategies.
Wang Q; Xin X; Dai Q; Sun M; Chen J; Mostafavi E; Shen Y; Li X
Pharmacol Ther; 2023 Oct; 250():108527. PubMed ID: 37703952
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of human Sonic Hedgehog (SHH) medulloblastoma stem-like cells.
Ronci M; Catanzaro G; Pieroni L; Po A; Besharat ZM; Greco V; Levi Mortera S; Screpanti I; Ferretti E; Urbani A
Mol Biosyst; 2015 Jun; 11(6):1603-11. PubMed ID: 25756958
[TBL] [Abstract][Full Text] [Related]
9. Genetics of medulloblastoma: clues for novel therapies.
Onvani S; Etame AB; Smith CA; Rutka JT
Expert Rev Neurother; 2010 May; 10(5):811-23. PubMed ID: 20420498
[TBL] [Abstract][Full Text] [Related]
10. MRI features as a helpful tool to predict the molecular subgroups of medulloblastoma: state of the art.
Colafati GS; Voicu IP; Carducci C; Miele E; Carai A; Di Loreto S; Marrazzo A; Cacchione A; Cecinati V; Tornesello A; Mastronuzzi A
Ther Adv Neurol Disord; 2018; 11():1756286418775375. PubMed ID: 29977341
[TBL] [Abstract][Full Text] [Related]
11. New Developments in the Pathogenesis, Therapeutic Targeting, and Treatment of Pediatric Medulloblastoma.
Fang FY; Rosenblum JS; Ho WS; Heiss JD
Cancers (Basel); 2022 May; 14(9):. PubMed ID: 35565414
[TBL] [Abstract][Full Text] [Related]
12. Exploring the Molecular Complexity of Medulloblastoma: Implications for Diagnosis and Treatment.
Rechberger JS; Toll SA; Vanbilloen WJF; Daniels DJ; Khatua S
Diagnostics (Basel); 2023 Jul; 13(14):. PubMed ID: 37510143
[TBL] [Abstract][Full Text] [Related]
13. Medulloblastoma: signalling a change in treatment.
Gilbertson RJ
Lancet Oncol; 2004 Apr; 5(4):209-18. PubMed ID: 15050952
[TBL] [Abstract][Full Text] [Related]
14. Medulloblastoma: presentation, diagnosis and management.
Packer RJ; Finlay JL
Oncology (Williston Park); 1988 Sep; 2(9):35-45, 48-9. PubMed ID: 3275066
[TBL] [Abstract][Full Text] [Related]
15. Medulloblastoma under Siege: Genetic and Molecular Dissection Concerning Recent Advances in Therapeutic Strategies.
Rawal ZD; Upadhyay VA; Patel DD; Trivedi TI
J Pediatr Neurosci; 2020; 15(3):175-182. PubMed ID: 33531929
[TBL] [Abstract][Full Text] [Related]
16. Neogenin1 is a Sonic Hedgehog target in medulloblastoma and is necessary for cell cycle progression.
Milla LA; Arros A; Espinoza N; Remke M; Kool M; Taylor MD; Pfister SM; Wainwright BJ; Palma V
Int J Cancer; 2014 Jan; 134(1):21-31. PubMed ID: 23775842
[TBL] [Abstract][Full Text] [Related]
17. Medulloblastoma stem cells: modeling tumor heterogeneity.
Manoranjan B; Venugopal C; McFarlane N; Doble BW; Dunn SE; Scheinemann K; Singh SK
Cancer Lett; 2013 Sep; 338(1):23-31. PubMed ID: 22796365
[TBL] [Abstract][Full Text] [Related]
18. New perspectives in the treatment of adult medulloblastoma in the era of molecular oncology.
Brandes AA; Bartolotti M; Marucci G; Ghimenton C; Agati R; Fioravanti A; Mascarin M; Volpin L; Ammannati F; Masotto B; Gardiman MP; De Biase D; Tallini G; Crisi G; Bartolini S; Franceschi E
Crit Rev Oncol Hematol; 2015 Jun; 94(3):348-59. PubMed ID: 25600839
[TBL] [Abstract][Full Text] [Related]
19. Novel MRI deformation-heterogeneity radiomic features are associated with molecular subgroups and overall survival in pediatric medulloblastoma: Preliminary findings from a multi-institutional study.
Iyer S; Ismail M; Tamrazi B; Salloum R; de Blank P; Margol A; Correa R; Chen J; Bera K; Statsevych V; Ho ML; Vaidya P; Verma R; Hawes D; Judkins A; Fu P; Madabhushi A; Tiwari P
Front Oncol; 2022; 12():915143. PubMed ID: 36620600
[TBL] [Abstract][Full Text] [Related]
20. Classic and desmoplastic medulloblastoma: complete case reports and characterizations of two new cell lines.
Holthouse DJ; Dallas PB; Ford J; Fabian V; Murch AR; Watson M; Wong G; Bertram C; Egli S; Baker DL; Kees UR
Neuropathology; 2009 Aug; 29(4):398-409. PubMed ID: 19077040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
